Mcl-1 expression is a predictive marker of response to gemcitabine plus nab-paclitaxel for metastatic pancreatic cancerMakiko Urabe(Osaka International Cancer Institute), Kazuyoshi Ohkawa(Osaka International Cancer Institute)Scientific ReportsSeptember 20, 202410.1038/s41598-024-73020-8Cited by 2SaveCiteExport RISWatch citationsRelated PapersClinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)|Hepatology Research|2023|267